# Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed

> **NCT00003053** · PHASE3 · UNKNOWN · sponsor: **European Institute of Oncology** · enrollment: 750 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** etoposide
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00003053
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1994-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003053, "Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*